脑膜炎球菌(meningococcus),学名为脑膜炎奈瑟球菌(N.meninyitidis),为流行性脑脊髓膜炎(流脑)的病原菌。脑膜炎球菌性脑膜炎是一种细菌性脑膜炎,因围绕大脑和脊髓的内皮发生严重感染而造成[1]。A群C群脑膜炎球菌多糖疫苗系用相应群的脑膜炎球菌培养液,分别提取和纯化,获得相应群的荚膜多糖抗原,加入适宜稳定剂后冻干制成,用于预防由相应群脑膜炎球菌引起的疾病。随着我国免疫规划的 Meningococcus (meningococcus), known as N. meningitidis (N. Meninyitidis), is the epidemic cerebrospinal meningitis (meningitis) pathogens. Meningococcal meningitis is a bacterial meningitis caused by a serious infection of the endothelium around the brain and spinal cord [1]. A group C meningococcal polysaccharide vaccine with the corresponding group of meningococcal culture medium were extracted and purified to obtain the corresponding group of capsular polysaccharide antigen, adding a suitable stabilizer and freeze-dried made for the prevention by the corresponding group Meningococcal disease. With our immunization program